COX-2s Left Out Of Drug Classes, Will Go Up Against Other NSAIDs
This article was originally published in The Pink Sheet Daily
Executive Summary
COX-2 inhibitors are among the drugs where Medicare coverage would be "recommended," but not required, under the U.S. Pharmacopeia's model formulary